nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—ovarian cancer	0.356	1	CiPCiCtD
Cisplatin—testicular cancer—ovarian cancer	0.0961	0.511	CtDrD
Cisplatin—germ cell cancer—ovarian cancer	0.092	0.489	CtDrD
Cisplatin—ATP7B—ovarian cancer	0.0892	0.561	CbGaD
Cisplatin—SOD1—ovarian cancer	0.0602	0.379	CbGaD
Cisplatin—SLC31A2—Carboplatin—ovarian cancer	0.0238	0.111	CbGbCtD
Cisplatin—GSTP1—Chlorambucil—ovarian cancer	0.0221	0.103	CbGbCtD
Cisplatin—ATP7A—Carboplatin—ovarian cancer	0.0172	0.08	CbGbCtD
Cisplatin—MT2A—Carboplatin—ovarian cancer	0.0172	0.08	CbGbCtD
Cisplatin—ATP7B—Carboplatin—ovarian cancer	0.0172	0.08	CbGbCtD
Cisplatin—MT1A—Carboplatin—ovarian cancer	0.0172	0.08	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—ovarian cancer	0.0137	0.0636	CbGbCtD
Cisplatin—SOD1—Carboplatin—ovarian cancer	0.0137	0.0636	CbGbCtD
Cisplatin—GSTT1—Carboplatin—ovarian cancer	0.0114	0.0532	CbGbCtD
Cisplatin—GSTM1—Carboplatin—ovarian cancer	0.00989	0.046	CbGbCtD
Cisplatin—ABCB1—ovarian cancer	0.00947	0.0596	CbGaD
Cisplatin—NQO1—Carboplatin—ovarian cancer	0.00785	0.0365	CbGbCtD
Cisplatin—GSTP1—Carboplatin—ovarian cancer	0.00715	0.0332	CbGbCtD
Cisplatin—NQO1—Doxorubicin—ovarian cancer	0.0045	0.0209	CbGbCtD
Cisplatin—MPO—Carboplatin—ovarian cancer	0.0041	0.0191	CbGbCtD
Cisplatin—XDH—Carboplatin—ovarian cancer	0.0041	0.0191	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—ovarian cancer	0.00376	0.0175	CbGbCtD
Cisplatin—ABCG2—Topotecan—ovarian cancer	0.00278	0.0129	CbGbCtD
Cisplatin—XDH—Doxorubicin—ovarian cancer	0.00235	0.0109	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—ovarian cancer	0.00181	0.00841	CbGbCtD
Cisplatin—ABCC2—Paclitaxel—ovarian cancer	0.00152	0.00709	CbGbCtD
Cisplatin—ABCC2—Carboplatin—ovarian cancer	0.00143	0.00667	CbGbCtD
Cisplatin—ABCG2—Paclitaxel—ovarian cancer	0.00138	0.00641	CbGbCtD
Cisplatin—ABCG2—Carboplatin—ovarian cancer	0.0013	0.00603	CbGbCtD
Cisplatin—ABCC2—Docetaxel—ovarian cancer	0.0011	0.00512	CbGbCtD
Cisplatin—ABCB1—Topotecan—ovarian cancer	0.001	0.00467	CbGbCtD
Cisplatin—ABCG2—Docetaxel—ovarian cancer	0.000996	0.00463	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—ovarian cancer	0.000821	0.00382	CbGbCtD
Cisplatin—BCHE—diaphragm—ovarian cancer	0.000796	0.0386	CbGeAlD
Cisplatin—ABCG2—Doxorubicin—ovarian cancer	0.000743	0.00345	CbGbCtD
Cisplatin—ABCB1—Vinorelbine—ovarian cancer	0.000707	0.00329	CbGbCtD
Cisplatin—NQO1—Vincristine—Vinorelbine—ovarian cancer	0.000557	1	CbGdCrCtD
Cisplatin—PTGS2—ovarian follicle—ovarian cancer	0.000531	0.0257	CbGeAlD
Cisplatin—CYP2B6—Doxorubicin—ovarian cancer	0.000522	0.00243	CbGbCtD
Cisplatin—CYP2C9—Paclitaxel—ovarian cancer	0.000512	0.00238	CbGbCtD
Cisplatin—GSTP1—oviduct—ovarian cancer	0.0005	0.0242	CbGeAlD
Cisplatin—ABCB1—Paclitaxel—ovarian cancer	0.000497	0.00231	CbGbCtD
Cisplatin—ABCB1—Docetaxel—ovarian cancer	0.000359	0.00167	CbGbCtD
Cisplatin—SLC31A2—myometrium—ovarian cancer	0.000348	0.0169	CbGeAlD
Cisplatin—ATP7A—myometrium—ovarian cancer	0.000307	0.0149	CbGeAlD
Cisplatin—SLC31A2—uterine cervix—ovarian cancer	0.000271	0.0131	CbGeAlD
Cisplatin—SOD1—myometrium—ovarian cancer	0.000268	0.013	CbGeAlD
Cisplatin—ATP7B—endometrium—ovarian cancer	0.000268	0.013	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—ovarian cancer	0.000268	0.00125	CbGbCtD
Cisplatin—SLC31A1—myometrium—ovarian cancer	0.000262	0.0127	CbGeAlD
Cisplatin—SLC31A2—decidua—ovarian cancer	0.000258	0.0125	CbGeAlD
Cisplatin—MT1A—female reproductive system—ovarian cancer	0.000248	0.012	CbGeAlD
Cisplatin—ATP7B—uterus—ovarian cancer	0.000247	0.012	CbGeAlD
Cisplatin—SLC31A2—endometrium—ovarian cancer	0.000245	0.0119	CbGeAlD
Cisplatin—ATP7A—epithelium—ovarian cancer	0.000241	0.0117	CbGeAlD
Cisplatin—ATP7A—uterine cervix—ovarian cancer	0.000239	0.0116	CbGeAlD
Cisplatin—MT2A—gonad—ovarian cancer	0.000231	0.0112	CbGeAlD
Cisplatin—ATP7A—decidua—ovarian cancer	0.000227	0.011	CbGeAlD
Cisplatin—ATP7B—female reproductive system—ovarian cancer	0.000222	0.0108	CbGeAlD
Cisplatin—ATP7A—endometrium—ovarian cancer	0.000216	0.0105	CbGeAlD
Cisplatin—SOD1—uterine cervix—ovarian cancer	0.000209	0.0101	CbGeAlD
Cisplatin—CYP4A11—vagina—ovarian cancer	0.000206	0.01	CbGeAlD
Cisplatin—MT2A—female reproductive system—ovarian cancer	0.000206	0.01	CbGeAlD
Cisplatin—SLC31A1—uterine cervix—ovarian cancer	0.000204	0.00986	CbGeAlD
Cisplatin—SLC31A2—female reproductive system—ovarian cancer	0.000203	0.00983	CbGeAlD
Cisplatin—ATP7B—female gonad—ovarian cancer	0.000202	0.00979	CbGeAlD
Cisplatin—GSTT1—female reproductive system—ovarian cancer	0.000202	0.00979	CbGeAlD
Cisplatin—XDH—uterine cervix—ovarian cancer	0.000201	0.00974	CbGeAlD
Cisplatin—ATP7B—vagina—ovarian cancer	0.000201	0.00973	CbGeAlD
Cisplatin—MT1A—testis—ovarian cancer	0.0002	0.00969	CbGeAlD
Cisplatin—SOD1—decidua—ovarian cancer	0.000199	0.00964	CbGeAlD
Cisplatin—SLC31A2—bone marrow—ovarian cancer	0.000192	0.00928	CbGeAlD
Cisplatin—SOD1—endometrium—ovarian cancer	0.000189	0.00915	CbGeAlD
Cisplatin—MT2A—female gonad—ovarian cancer	0.000188	0.0091	CbGeAlD
Cisplatin—SLC31A2—female gonad—ovarian cancer	0.000185	0.00894	CbGeAlD
Cisplatin—SLC31A1—endometrium—ovarian cancer	0.000184	0.00892	CbGeAlD
Cisplatin—SLC31A2—vagina—ovarian cancer	0.000184	0.00889	CbGeAlD
Cisplatin—XDH—endometrium—ovarian cancer	0.000182	0.00881	CbGeAlD
Cisplatin—ATP7B—testis—ovarian cancer	0.000179	0.00868	CbGeAlD
Cisplatin—NQO1—myometrium—ovarian cancer	0.000179	0.00867	CbGeAlD
Cisplatin—SOD1—uterus—ovarian cancer	0.000174	0.00843	CbGeAlD
Cisplatin—SLC31A1—gonad—ovarian cancer	0.000171	0.00827	CbGeAlD
Cisplatin—ATP7A—bone marrow—ovarian cancer	0.000169	0.00818	CbGeAlD
Cisplatin—GSTM1—gonad—ovarian cancer	0.000167	0.00807	CbGeAlD
Cisplatin—MT2A—testis—ovarian cancer	0.000167	0.00807	CbGeAlD
Cisplatin—SLC31A2—testis—ovarian cancer	0.000164	0.00793	CbGeAlD
Cisplatin—ATP7A—female gonad—ovarian cancer	0.000163	0.00788	CbGeAlD
Cisplatin—ATP7A—vagina—ovarian cancer	0.000162	0.00783	CbGeAlD
Cisplatin—GSTP1—myometrium—ovarian cancer	0.00016	0.00774	CbGeAlD
Cisplatin—GSTP1—embryo—ovarian cancer	0.000154	0.00745	CbGeAlD
Cisplatin—SLC31A1—female reproductive system—ovarian cancer	0.000152	0.00739	CbGeAlD
Cisplatin—XDH—female reproductive system—ovarian cancer	0.000151	0.0073	CbGeAlD
Cisplatin—GSTM1—female reproductive system—ovarian cancer	0.000149	0.00721	CbGeAlD
Cisplatin—ABCC5—uterine cervix—ovarian cancer	0.000149	0.00721	CbGeAlD
Cisplatin—SOD1—bone marrow—ovarian cancer	0.000148	0.00716	CbGeAlD
Cisplatin—MT1A—lymph node—ovarian cancer	0.000145	0.00702	CbGeAlD
Cisplatin—ATP7A—testis—ovarian cancer	0.000144	0.00699	CbGeAlD
Cisplatin—SLC31A1—bone marrow—ovarian cancer	0.000144	0.00697	CbGeAlD
Cisplatin—SOD1—female gonad—ovarian cancer	0.000142	0.0069	CbGeAlD
Cisplatin—ABCC5—decidua—ovarian cancer	0.000142	0.00687	CbGeAlD
Cisplatin—SOD1—vagina—ovarian cancer	0.000142	0.00685	CbGeAlD
Cisplatin—NQO1—epithelium—ovarian cancer	0.00014	0.0068	CbGeAlD
Cisplatin—NQO1—uterine cervix—ovarian cancer	0.000139	0.00674	CbGeAlD
Cisplatin—SLC31A1—female gonad—ovarian cancer	0.000139	0.00672	CbGeAlD
Cisplatin—SLC31A1—vagina—ovarian cancer	0.000138	0.00668	CbGeAlD
Cisplatin—XDH—vagina—ovarian cancer	0.000136	0.0066	CbGeAlD
Cisplatin—GSTM1—female gonad—ovarian cancer	0.000135	0.00656	CbGeAlD
Cisplatin—NQO1—decidua—ovarian cancer	0.000133	0.00643	CbGeAlD
Cisplatin—ATP7B—lymph node—ovarian cancer	0.00013	0.00629	CbGeAlD
Cisplatin—MPO—epithelium—ovarian cancer	0.000129	0.00625	CbGeAlD
Cisplatin—SOD1—testis—ovarian cancer	0.000126	0.00612	CbGeAlD
Cisplatin—NQO1—endometrium—ovarian cancer	0.000126	0.0061	CbGeAlD
Cisplatin—GSTP1—epithelium—ovarian cancer	0.000125	0.00608	CbGeAlD
Cisplatin—GSTP1—uterine cervix—ovarian cancer	0.000124	0.00603	CbGeAlD
Cisplatin—SLC31A1—testis—ovarian cancer	0.000123	0.00596	CbGeAlD
Cisplatin—GSTM1—testis—ovarian cancer	0.00012	0.00582	CbGeAlD
Cisplatin—ABCC3—decidua—ovarian cancer	0.000119	0.00577	CbGeAlD
Cisplatin—SLC31A2—lymph node—ovarian cancer	0.000119	0.00575	CbGeAlD
Cisplatin—GSTP1—decidua—ovarian cancer	0.000119	0.00574	CbGeAlD
Cisplatin—NQO1—uterus—ovarian cancer	0.000116	0.00562	CbGeAlD
Cisplatin—GSTP1—endometrium—ovarian cancer	0.000113	0.00545	CbGeAlD
Cisplatin—ABCC5—bone marrow—ovarian cancer	0.000105	0.0051	CbGeAlD
Cisplatin—ATP7A—lymph node—ovarian cancer	0.000105	0.00507	CbGeAlD
Cisplatin—GSTP1—gonad—ovarian cancer	0.000104	0.00506	CbGeAlD
Cisplatin—NQO1—female reproductive system—ovarian cancer	0.000104	0.00505	CbGeAlD
Cisplatin—GSTP1—uterus—ovarian cancer	0.000104	0.00502	CbGeAlD
Cisplatin—ABCC5—female gonad—ovarian cancer	0.000101	0.00491	CbGeAlD
Cisplatin—ABCC5—vagina—ovarian cancer	0.000101	0.00488	CbGeAlD
Cisplatin—BCHE—myometrium—ovarian cancer	9.68e-05	0.00469	CbGeAlD
Cisplatin—NQO1—female gonad—ovarian cancer	9.49e-05	0.0046	CbGeAlD
Cisplatin—NQO1—vagina—ovarian cancer	9.43e-05	0.00457	CbGeAlD
Cisplatin—ABCC3—female reproductive system—ovarian cancer	9.36e-05	0.00453	CbGeAlD
Cisplatin—ABCG2—myometrium—ovarian cancer	9.36e-05	0.00453	CbGeAlD
Cisplatin—GSTP1—female reproductive system—ovarian cancer	9.32e-05	0.00452	CbGeAlD
Cisplatin—SOD1—lymph node—ovarian cancer	9.15e-05	0.00443	CbGeAlD
Cisplatin—MPO—bone marrow—ovarian cancer	9.05e-05	0.00439	CbGeAlD
Cisplatin—ABCC5—testis—ovarian cancer	9e-05	0.00436	CbGeAlD
Cisplatin—SLC31A1—lymph node—ovarian cancer	8.92e-05	0.00432	CbGeAlD
Cisplatin—GSTP1—bone marrow—ovarian cancer	8.8e-05	0.00426	CbGeAlD
Cisplatin—GSTM1—lymph node—ovarian cancer	8.71e-05	0.00422	CbGeAlD
Cisplatin—ABCC3—female gonad—ovarian cancer	8.52e-05	0.00413	CbGeAlD
Cisplatin—GSTP1—female gonad—ovarian cancer	8.48e-05	0.00411	CbGeAlD
Cisplatin—GSTP1—vagina—ovarian cancer	8.43e-05	0.00408	CbGeAlD
Cisplatin—NQO1—testis—ovarian cancer	8.42e-05	0.00408	CbGeAlD
Cisplatin—MPO—testis—ovarian cancer	7.74e-05	0.00375	CbGeAlD
Cisplatin—ABCC3—testis—ovarian cancer	7.56e-05	0.00366	CbGeAlD
Cisplatin—BCHE—uterine cervix—ovarian cancer	7.53e-05	0.00365	CbGeAlD
Cisplatin—GSTP1—testis—ovarian cancer	7.52e-05	0.00364	CbGeAlD
Cisplatin—ABCC2—female reproductive system—ovarian cancer	7.48e-05	0.00362	CbGeAlD
Cisplatin—PTGS2—myometrium—ovarian cancer	7.46e-05	0.00361	CbGeAlD
Cisplatin—ABCG2—uterine cervix—ovarian cancer	7.28e-05	0.00353	CbGeAlD
Cisplatin—PTGS2—embryo—ovarian cancer	7.17e-05	0.00348	CbGeAlD
Cisplatin—ABCG2—decidua—ovarian cancer	6.94e-05	0.00336	CbGeAlD
Cisplatin—BCHE—endometrium—ovarian cancer	6.81e-05	0.0033	CbGeAlD
Cisplatin—ABCG2—endometrium—ovarian cancer	6.59e-05	0.00319	CbGeAlD
Cisplatin—ABCC5—lymph node—ovarian cancer	6.52e-05	0.00316	CbGeAlD
Cisplatin—BCHE—uterus—ovarian cancer	6.28e-05	0.00304	CbGeAlD
Cisplatin—NQO1—lymph node—ovarian cancer	6.1e-05	0.00296	CbGeAlD
Cisplatin—ABCG2—uterus—ovarian cancer	6.07e-05	0.00294	CbGeAlD
Cisplatin—ABCC2—testis—ovarian cancer	6.04e-05	0.00292	CbGeAlD
Cisplatin—PTGS2—epithelium—ovarian cancer	5.85e-05	0.00284	CbGeAlD
Cisplatin—PTGS2—uterine cervix—ovarian cancer	5.8e-05	0.00281	CbGeAlD
Cisplatin—BCHE—female reproductive system—ovarian cancer	5.64e-05	0.00273	CbGeAlD
Cisplatin—CYP2B6—gonad—ovarian cancer	5.64e-05	0.00273	CbGeAlD
Cisplatin—MPO—lymph node—ovarian cancer	5.61e-05	0.00272	CbGeAlD
Cisplatin—ABCC3—lymph node—ovarian cancer	5.48e-05	0.00265	CbGeAlD
Cisplatin—GSTP1—lymph node—ovarian cancer	5.45e-05	0.00264	CbGeAlD
Cisplatin—BCHE—bone marrow—ovarian cancer	5.33e-05	0.00258	CbGeAlD
Cisplatin—PTGS2—endometrium—ovarian cancer	5.25e-05	0.00254	CbGeAlD
Cisplatin—ABCG2—bone marrow—ovarian cancer	5.15e-05	0.00249	CbGeAlD
Cisplatin—BCHE—vagina—ovarian cancer	5.11e-05	0.00247	CbGeAlD
Cisplatin—CYP2B6—female reproductive system—ovarian cancer	5.03e-05	0.00244	CbGeAlD
Cisplatin—CYP2C9—female reproductive system—ovarian cancer	4.98e-05	0.00241	CbGeAlD
Cisplatin—ABCG2—female gonad—ovarian cancer	4.96e-05	0.0024	CbGeAlD
Cisplatin—ABCG2—vagina—ovarian cancer	4.93e-05	0.00239	CbGeAlD
Cisplatin—PTGS2—uterus—ovarian cancer	4.84e-05	0.00234	CbGeAlD
Cisplatin—ABCB1—myometrium—ovarian cancer	4.61e-05	0.00223	CbGeAlD
Cisplatin—BCHE—testis—ovarian cancer	4.56e-05	0.00221	CbGeAlD
Cisplatin—CYP2B6—vagina—ovarian cancer	4.55e-05	0.0022	CbGeAlD
Cisplatin—ABCB1—embryo—ovarian cancer	4.44e-05	0.00215	CbGeAlD
Cisplatin—ABCG2—testis—ovarian cancer	4.4e-05	0.00213	CbGeAlD
Cisplatin—ABCC2—lymph node—ovarian cancer	4.38e-05	0.00212	CbGeAlD
Cisplatin—PTGS2—female reproductive system—ovarian cancer	4.35e-05	0.00211	CbGeAlD
Cisplatin—PTGS2—bone marrow—ovarian cancer	4.11e-05	0.00199	CbGeAlD
Cisplatin—CYP2B6—testis—ovarian cancer	4.06e-05	0.00197	CbGeAlD
Cisplatin—PTGS2—female gonad—ovarian cancer	3.96e-05	0.00192	CbGeAlD
Cisplatin—PTGS2—vagina—ovarian cancer	3.93e-05	0.00191	CbGeAlD
Cisplatin—ABCB1—epithelium—ovarian cancer	3.62e-05	0.00175	CbGeAlD
Cisplatin—ABCB1—uterine cervix—ovarian cancer	3.59e-05	0.00174	CbGeAlD
Cisplatin—ABCB1—decidua—ovarian cancer	3.42e-05	0.00166	CbGeAlD
Cisplatin—BCHE—lymph node—ovarian cancer	3.3e-05	0.0016	CbGeAlD
Cisplatin—ABCB1—endometrium—ovarian cancer	3.25e-05	0.00157	CbGeAlD
Cisplatin—ABCG2—lymph node—ovarian cancer	3.19e-05	0.00155	CbGeAlD
Cisplatin—ABCB1—gonad—ovarian cancer	3.01e-05	0.00146	CbGeAlD
Cisplatin—ABCB1—uterus—ovarian cancer	2.99e-05	0.00145	CbGeAlD
Cisplatin—Alopecia—Paclitaxel—ovarian cancer	2.74e-05	0.000707	CcSEcCtD
Cisplatin—Vomiting—Chlorambucil—ovarian cancer	2.73e-05	0.000706	CcSEcCtD
Cisplatin—Malnutrition—Paclitaxel—ovarian cancer	2.7e-05	0.000697	CcSEcCtD
Cisplatin—Erythema—Paclitaxel—ovarian cancer	2.7e-05	0.000697	CcSEcCtD
Cisplatin—Feeling abnormal—Vinorelbine—ovarian cancer	2.7e-05	0.000697	CcSEcCtD
Cisplatin—ABCB1—female reproductive system—ovarian cancer	2.69e-05	0.0013	CbGeAlD
Cisplatin—Asthenia—Melphalan—ovarian cancer	2.69e-05	0.000694	CcSEcCtD
Cisplatin—Flatulence—Paclitaxel—ovarian cancer	2.66e-05	0.000687	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Epirubicin—ovarian cancer	2.65e-05	0.000683	CcSEcCtD
Cisplatin—Diarrhoea—Topotecan—ovarian cancer	2.62e-05	0.000676	CcSEcCtD
Cisplatin—Cerebrovascular accident—Epirubicin—ovarian cancer	2.61e-05	0.000675	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—ovarian cancer	2.61e-05	0.000675	CcSEcCtD
Cisplatin—Urinary tract disorder—Docetaxel—ovarian cancer	2.59e-05	0.00067	CcSEcCtD
Cisplatin—Muscle spasms—Paclitaxel—ovarian cancer	2.59e-05	0.00067	CcSEcCtD
Cisplatin—Body temperature increased—Vinorelbine—ovarian cancer	2.59e-05	0.000668	CcSEcCtD
Cisplatin—Connective tissue disorder—Docetaxel—ovarian cancer	2.58e-05	0.000667	CcSEcCtD
Cisplatin—Urethral disorder—Docetaxel—ovarian cancer	2.57e-05	0.000665	CcSEcCtD
Cisplatin—Hyponatraemia—Epirubicin—ovarian cancer	2.57e-05	0.000664	CcSEcCtD
Cisplatin—Renal failure acute—Doxorubicin—ovarian cancer	2.57e-05	0.000663	CcSEcCtD
Cisplatin—Diarrhoea—Melphalan—ovarian cancer	2.56e-05	0.000662	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	2.56e-05	0.000661	CcSEcCtD
Cisplatin—Nausea—Chlorambucil—ovarian cancer	2.55e-05	0.000659	CcSEcCtD
Cisplatin—PTGS2—lymph node—ovarian cancer	2.54e-05	0.00123	CbGeAlD
Cisplatin—Vision blurred—Paclitaxel—ovarian cancer	2.54e-05	0.000657	CcSEcCtD
Cisplatin—ABCB1—bone marrow—ovarian cancer	2.54e-05	0.00123	CbGeAlD
Cisplatin—Visual impairment—Docetaxel—ovarian cancer	2.53e-05	0.000654	CcSEcCtD
Cisplatin—Tremor—Paclitaxel—ovarian cancer	2.53e-05	0.000653	CcSEcCtD
Cisplatin—Ill-defined disorder—Paclitaxel—ovarian cancer	2.5e-05	0.000646	CcSEcCtD
Cisplatin—Anaemia—Paclitaxel—ovarian cancer	2.49e-05	0.000644	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—ovarian cancer	2.47e-05	0.000639	CcSEcCtD
Cisplatin—Eye disorder—Docetaxel—ovarian cancer	2.45e-05	0.000634	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	2.45e-05	0.000632	CcSEcCtD
Cisplatin—ABCB1—female gonad—ovarian cancer	2.45e-05	0.00119	CbGeAlD
Cisplatin—Flushing—Docetaxel—ovarian cancer	2.44e-05	0.00063	CcSEcCtD
Cisplatin—Cardiac disorder—Docetaxel—ovarian cancer	2.44e-05	0.00063	CcSEcCtD
Cisplatin—ABCB1—vagina—ovarian cancer	2.43e-05	0.00118	CbGeAlD
Cisplatin—Vomiting—Topotecan—ovarian cancer	2.43e-05	0.000628	CcSEcCtD
Cisplatin—Malaise—Paclitaxel—ovarian cancer	2.43e-05	0.000628	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—ovarian cancer	2.42e-05	0.000625	CcSEcCtD
Cisplatin—Leukopenia—Paclitaxel—ovarian cancer	2.41e-05	0.000624	CcSEcCtD
Cisplatin—Rash—Topotecan—ovarian cancer	2.41e-05	0.000623	CcSEcCtD
Cisplatin—Hypersensitivity—Vinorelbine—ovarian cancer	2.41e-05	0.000623	CcSEcCtD
Cisplatin—Dermatitis—Topotecan—ovarian cancer	2.41e-05	0.000623	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—ovarian cancer	2.4e-05	0.00062	CcSEcCtD
Cisplatin—Vomiting—Melphalan—ovarian cancer	2.38e-05	0.000615	CcSEcCtD
Cisplatin—Dehydration—Epirubicin—ovarian cancer	2.38e-05	0.000615	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—ovarian cancer	2.38e-05	0.000615	CcSEcCtD
Cisplatin—Immune system disorder—Docetaxel—ovarian cancer	2.37e-05	0.000613	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	2.37e-05	0.000612	CcSEcCtD
Cisplatin—Mediastinal disorder—Docetaxel—ovarian cancer	2.37e-05	0.000611	CcSEcCtD
Cisplatin—Rash—Melphalan—ovarian cancer	2.36e-05	0.00061	CcSEcCtD
Cisplatin—Dermatitis—Melphalan—ovarian cancer	2.36e-05	0.00061	CcSEcCtD
Cisplatin—Asthenia—Vinorelbine—ovarian cancer	2.35e-05	0.000607	CcSEcCtD
Cisplatin—Arrhythmia—Docetaxel—ovarian cancer	2.35e-05	0.000606	CcSEcCtD
Cisplatin—Orthostatic hypotension—Epirubicin—ovarian cancer	2.34e-05	0.000604	CcSEcCtD
Cisplatin—Convulsion—Paclitaxel—ovarian cancer	2.34e-05	0.000604	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—ovarian cancer	2.33e-05	0.000602	CcSEcCtD
Cisplatin—Alopecia—Docetaxel—ovarian cancer	2.32e-05	0.0006	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—ovarian cancer	2.31e-05	0.000598	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	2.31e-05	0.000596	CcSEcCtD
Cisplatin—Myalgia—Paclitaxel—ovarian cancer	2.3e-05	0.000593	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—ovarian cancer	2.29e-05	0.000591	CcSEcCtD
Cisplatin—Anxiety—Paclitaxel—ovarian cancer	2.29e-05	0.000591	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—ovarian cancer	2.29e-05	0.000591	CcSEcCtD
Cisplatin—Erythema—Docetaxel—ovarian cancer	2.29e-05	0.000591	CcSEcCtD
Cisplatin—Malnutrition—Docetaxel—ovarian cancer	2.29e-05	0.000591	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	2.28e-05	0.000589	CcSEcCtD
Cisplatin—Nausea—Topotecan—ovarian cancer	2.27e-05	0.000587	CcSEcCtD
Cisplatin—Discomfort—Paclitaxel—ovarian cancer	2.27e-05	0.000586	CcSEcCtD
Cisplatin—Diarrhoea—Vinorelbine—ovarian cancer	2.24e-05	0.000578	CcSEcCtD
Cisplatin—Nausea—Melphalan—ovarian cancer	2.23e-05	0.000575	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—ovarian cancer	2.22e-05	0.000573	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—ovarian cancer	2.2e-05	0.000569	CcSEcCtD
Cisplatin—Oedema—Paclitaxel—ovarian cancer	2.2e-05	0.000569	CcSEcCtD
Cisplatin—Anaphylactic shock—Paclitaxel—ovarian cancer	2.2e-05	0.000569	CcSEcCtD
Cisplatin—Muscle spasms—Docetaxel—ovarian cancer	2.2e-05	0.000568	CcSEcCtD
Cisplatin—Infection—Paclitaxel—ovarian cancer	2.19e-05	0.000565	CcSEcCtD
Cisplatin—ABCB1—testis—ovarian cancer	2.17e-05	0.00105	CbGeAlD
Cisplatin—Pancreatitis—Epirubicin—ovarian cancer	2.17e-05	0.000561	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—ovarian cancer	2.16e-05	0.000559	CcSEcCtD
Cisplatin—Nervous system disorder—Paclitaxel—ovarian cancer	2.16e-05	0.000558	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—ovarian cancer	2.16e-05	0.000557	CcSEcCtD
Cisplatin—Thrombocytopenia—Paclitaxel—ovarian cancer	2.16e-05	0.000557	CcSEcCtD
Cisplatin—Tachycardia—Paclitaxel—ovarian cancer	2.15e-05	0.000555	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—ovarian cancer	2.14e-05	0.000553	CcSEcCtD
Cisplatin—Skin disorder—Paclitaxel—ovarian cancer	2.14e-05	0.000552	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	2.13e-05	0.000551	CcSEcCtD
Cisplatin—Hyperhidrosis—Paclitaxel—ovarian cancer	2.13e-05	0.00055	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—ovarian cancer	2.12e-05	0.000547	CcSEcCtD
Cisplatin—Anaemia—Docetaxel—ovarian cancer	2.11e-05	0.000546	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—ovarian cancer	2.1e-05	0.000543	CcSEcCtD
Cisplatin—Anorexia—Paclitaxel—ovarian cancer	2.1e-05	0.000542	CcSEcCtD
Cisplatin—Vomiting—Vinorelbine—ovarian cancer	2.08e-05	0.000538	CcSEcCtD
Cisplatin—Rash—Vinorelbine—ovarian cancer	2.06e-05	0.000533	CcSEcCtD
Cisplatin—Dermatitis—Vinorelbine—ovarian cancer	2.06e-05	0.000533	CcSEcCtD
Cisplatin—Hypotension—Paclitaxel—ovarian cancer	2.06e-05	0.000531	CcSEcCtD
Cisplatin—Leukopenia—Docetaxel—ovarian cancer	2.05e-05	0.000529	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—ovarian cancer	2.01e-05	0.000519	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	2.01e-05	0.000518	CcSEcCtD
Cisplatin—Convulsion—Docetaxel—ovarian cancer	1.98e-05	0.000512	CcSEcCtD
Cisplatin—Paraesthesia—Paclitaxel—ovarian cancer	1.98e-05	0.000511	CcSEcCtD
Cisplatin—Dyspnoea—Paclitaxel—ovarian cancer	1.96e-05	0.000507	CcSEcCtD
Cisplatin—Myalgia—Docetaxel—ovarian cancer	1.95e-05	0.000503	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—ovarian cancer	1.94e-05	0.000502	CcSEcCtD
Cisplatin—Nausea—Vinorelbine—ovarian cancer	1.94e-05	0.000502	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—ovarian cancer	1.94e-05	0.000501	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—ovarian cancer	1.93e-05	0.0005	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	1.93e-05	0.000499	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—ovarian cancer	1.92e-05	0.000497	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—ovarian cancer	1.92e-05	0.000495	CcSEcCtD
Cisplatin—Decreased appetite—Paclitaxel—ovarian cancer	1.91e-05	0.000494	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	1.9e-05	0.000491	CcSEcCtD
Cisplatin—Pain—Paclitaxel—ovarian cancer	1.88e-05	0.000486	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—ovarian cancer	1.87e-05	0.000482	CcSEcCtD
Cisplatin—Oedema—Docetaxel—ovarian cancer	1.87e-05	0.000482	CcSEcCtD
Cisplatin—Anaphylactic shock—Docetaxel—ovarian cancer	1.87e-05	0.000482	CcSEcCtD
Cisplatin—Infection—Docetaxel—ovarian cancer	1.85e-05	0.000479	CcSEcCtD
Cisplatin—Nervous system disorder—Docetaxel—ovarian cancer	1.83e-05	0.000473	CcSEcCtD
Cisplatin—Thrombocytopenia—Docetaxel—ovarian cancer	1.83e-05	0.000472	CcSEcCtD
Cisplatin—Tachycardia—Docetaxel—ovarian cancer	1.82e-05	0.00047	CcSEcCtD
Cisplatin—Feeling abnormal—Paclitaxel—ovarian cancer	1.81e-05	0.000469	CcSEcCtD
Cisplatin—Skin disorder—Docetaxel—ovarian cancer	1.81e-05	0.000468	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—ovarian cancer	1.8e-05	0.000466	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—ovarian cancer	1.79e-05	0.000464	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—ovarian cancer	1.79e-05	0.000462	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—ovarian cancer	1.78e-05	0.00046	CcSEcCtD
Cisplatin—Anorexia—Docetaxel—ovarian cancer	1.78e-05	0.000459	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—ovarian cancer	1.77e-05	0.000458	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—ovarian cancer	1.75e-05	0.000452	CcSEcCtD
Cisplatin—Hypotension—Docetaxel—ovarian cancer	1.74e-05	0.00045	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—ovarian cancer	1.74e-05	0.00045	CcSEcCtD
Cisplatin—Body temperature increased—Paclitaxel—ovarian cancer	1.74e-05	0.00045	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—ovarian cancer	1.74e-05	0.000449	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—ovarian cancer	1.73e-05	0.000446	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—ovarian cancer	1.71e-05	0.000441	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	1.7e-05	0.000439	CcSEcCtD
Cisplatin—Paraesthesia—Docetaxel—ovarian cancer	1.68e-05	0.000433	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—ovarian cancer	1.67e-05	0.000431	CcSEcCtD
Cisplatin—Dyspnoea—Docetaxel—ovarian cancer	1.66e-05	0.00043	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—ovarian cancer	1.66e-05	0.000428	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—ovarian cancer	1.65e-05	0.000427	CcSEcCtD
Cisplatin—Flushing—Epirubicin—ovarian cancer	1.64e-05	0.000425	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—ovarian cancer	1.64e-05	0.000425	CcSEcCtD
Cisplatin—Decreased appetite—Docetaxel—ovarian cancer	1.62e-05	0.000419	CcSEcCtD
Cisplatin—Hypersensitivity—Paclitaxel—ovarian cancer	1.62e-05	0.000419	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—ovarian cancer	1.62e-05	0.000418	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Docetaxel—ovarian cancer	1.61e-05	0.000416	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—ovarian cancer	1.61e-05	0.000416	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—ovarian cancer	1.61e-05	0.000415	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—ovarian cancer	1.6e-05	0.000413	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—ovarian cancer	1.6e-05	0.000412	CcSEcCtD
Cisplatin—Pain—Docetaxel—ovarian cancer	1.6e-05	0.000412	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—ovarian cancer	1.58e-05	0.000409	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—ovarian cancer	1.58e-05	0.000408	CcSEcCtD
Cisplatin—Asthenia—Paclitaxel—ovarian cancer	1.58e-05	0.000408	CcSEcCtD
Cisplatin—ABCB1—lymph node—ovarian cancer	1.57e-05	0.000762	CbGeAlD
Cisplatin—Alopecia—Epirubicin—ovarian cancer	1.57e-05	0.000404	CcSEcCtD
Cisplatin—Erythema—Epirubicin—ovarian cancer	1.54e-05	0.000398	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—ovarian cancer	1.54e-05	0.000398	CcSEcCtD
Cisplatin—Feeling abnormal—Docetaxel—ovarian cancer	1.54e-05	0.000397	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—ovarian cancer	1.53e-05	0.000396	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—ovarian cancer	1.53e-05	0.000395	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—ovarian cancer	1.52e-05	0.000393	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—ovarian cancer	1.52e-05	0.000393	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—ovarian cancer	1.52e-05	0.000393	CcSEcCtD
Cisplatin—Diarrhoea—Paclitaxel—ovarian cancer	1.51e-05	0.000389	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—ovarian cancer	1.48e-05	0.000383	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—ovarian cancer	1.48e-05	0.000382	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—ovarian cancer	1.48e-05	0.000382	CcSEcCtD
Cisplatin—Body temperature increased—Docetaxel—ovarian cancer	1.48e-05	0.000381	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—ovarian cancer	1.46e-05	0.000378	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—ovarian cancer	1.45e-05	0.000375	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—ovarian cancer	1.45e-05	0.000374	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—ovarian cancer	1.43e-05	0.00037	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—ovarian cancer	1.43e-05	0.000369	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—ovarian cancer	1.43e-05	0.000369	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—ovarian cancer	1.43e-05	0.000368	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—ovarian cancer	1.41e-05	0.000363	CcSEcCtD
Cisplatin—Vomiting—Paclitaxel—ovarian cancer	1.4e-05	0.000362	CcSEcCtD
Cisplatin—Malaise—Epirubicin—ovarian cancer	1.39e-05	0.000359	CcSEcCtD
Cisplatin—Rash—Paclitaxel—ovarian cancer	1.39e-05	0.000359	CcSEcCtD
Cisplatin—Dermatitis—Paclitaxel—ovarian cancer	1.39e-05	0.000358	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—ovarian cancer	1.38e-05	0.000357	CcSEcCtD
Cisplatin—Hypersensitivity—Docetaxel—ovarian cancer	1.37e-05	0.000355	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—ovarian cancer	1.37e-05	0.000354	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—ovarian cancer	1.34e-05	0.000347	CcSEcCtD
Cisplatin—Asthenia—Docetaxel—ovarian cancer	1.34e-05	0.000346	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—ovarian cancer	1.34e-05	0.000345	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—ovarian cancer	1.32e-05	0.000342	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—ovarian cancer	1.32e-05	0.000341	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—ovarian cancer	1.31e-05	0.000339	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—ovarian cancer	1.31e-05	0.000338	CcSEcCtD
Cisplatin—Nausea—Paclitaxel—ovarian cancer	1.31e-05	0.000338	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.3e-05	0.000337	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—ovarian cancer	1.3e-05	0.000335	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—ovarian cancer	1.29e-05	0.000332	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—ovarian cancer	1.28e-05	0.00033	CcSEcCtD
Cisplatin—Diarrhoea—Docetaxel—ovarian cancer	1.28e-05	0.00033	CcSEcCtD
Cisplatin—Oedema—Epirubicin—ovarian cancer	1.26e-05	0.000325	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—ovarian cancer	1.26e-05	0.000325	CcSEcCtD
Cisplatin—Infection—Epirubicin—ovarian cancer	1.25e-05	0.000323	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—ovarian cancer	1.24e-05	0.000319	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—ovarian cancer	1.23e-05	0.000319	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—ovarian cancer	1.23e-05	0.000318	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—ovarian cancer	1.23e-05	0.000317	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—ovarian cancer	1.22e-05	0.000316	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—ovarian cancer	1.22e-05	0.000314	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—ovarian cancer	1.21e-05	0.000314	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—ovarian cancer	1.21e-05	0.000313	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.21e-05	0.000312	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—ovarian cancer	1.2e-05	0.00031	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—ovarian cancer	1.2e-05	0.00031	CcSEcCtD
Cisplatin—Vomiting—Docetaxel—ovarian cancer	1.19e-05	0.000306	CcSEcCtD
Cisplatin—Rash—Docetaxel—ovarian cancer	1.18e-05	0.000304	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—ovarian cancer	1.18e-05	0.000304	CcSEcCtD
Cisplatin—Dermatitis—Docetaxel—ovarian cancer	1.18e-05	0.000304	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—ovarian cancer	1.16e-05	0.000301	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—ovarian cancer	1.16e-05	0.000301	CcSEcCtD
Cisplatin—Infection—Doxorubicin—ovarian cancer	1.16e-05	0.000299	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.15e-05	0.000296	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—ovarian cancer	1.14e-05	0.000295	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—ovarian cancer	1.14e-05	0.000295	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—ovarian cancer	1.14e-05	0.000294	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—ovarian cancer	1.13e-05	0.000292	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—ovarian cancer	1.13e-05	0.000292	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—ovarian cancer	1.13e-05	0.000291	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—ovarian cancer	1.12e-05	0.00029	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—ovarian cancer	1.11e-05	0.000287	CcSEcCtD
Cisplatin—Nausea—Docetaxel—ovarian cancer	1.11e-05	0.000286	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—ovarian cancer	1.09e-05	0.000283	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—ovarian cancer	1.09e-05	0.000281	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.09e-05	0.000281	CcSEcCtD
Cisplatin—Pain—Epirubicin—ovarian cancer	1.08e-05	0.000278	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.06e-05	0.000274	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—ovarian cancer	1.05e-05	0.00027	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—ovarian cancer	1.04e-05	0.000268	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—ovarian cancer	1.04e-05	0.000268	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—ovarian cancer	1.01e-05	0.000261	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.01e-05	0.00026	CcSEcCtD
Cisplatin—Pain—Doxorubicin—ovarian cancer	9.96e-06	0.000257	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—ovarian cancer	9.95e-06	0.000257	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—ovarian cancer	9.6e-06	0.000248	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—ovarian cancer	9.27e-06	0.00024	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—ovarian cancer	9.21e-06	0.000238	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—ovarian cancer	9.03e-06	0.000233	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—ovarian cancer	8.61e-06	0.000222	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—ovarian cancer	8.58e-06	0.000222	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—ovarian cancer	8.36e-06	0.000216	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—ovarian cancer	8e-06	0.000207	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—ovarian cancer	7.97e-06	0.000206	CcSEcCtD
Cisplatin—Rash—Epirubicin—ovarian cancer	7.94e-06	0.000205	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—ovarian cancer	7.93e-06	0.000205	CcSEcCtD
Cisplatin—Nausea—Epirubicin—ovarian cancer	7.48e-06	0.000193	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—ovarian cancer	7.4e-06	0.000191	CcSEcCtD
Cisplatin—Rash—Doxorubicin—ovarian cancer	7.34e-06	0.00019	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—ovarian cancer	7.34e-06	0.000189	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—ovarian cancer	6.92e-06	0.000179	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.55e-06	0.000114	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.55e-06	0.000114	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.52e-06	0.000113	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPP2R1A—ovarian cancer	2.5e-06	0.000112	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CAV1—ovarian cancer	2.49e-06	0.000111	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.49e-06	0.000111	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CB—ovarian cancer	2.44e-06	0.000109	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MAPK1—ovarian cancer	2.44e-06	0.000109	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.42e-06	0.000108	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.42e-06	0.000108	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYTB—ovarian cancer	2.41e-06	0.000108	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.41e-06	0.000108	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.4e-06	0.000108	CbGpPWpGaD
Cisplatin—MT2A—Immune System—AKT1—ovarian cancer	2.39e-06	0.000107	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CD—ovarian cancer	2.38e-06	0.000107	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CD—ovarian cancer	2.38e-06	0.000106	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CG—ovarian cancer	2.37e-06	0.000106	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—FASN—ovarian cancer	2.36e-06	0.000106	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.36e-06	0.000106	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.34e-06	0.000105	CbGpPWpGaD
Cisplatin—PTGS2—Disease—XIAP—ovarian cancer	2.33e-06	0.000104	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC5A5—ovarian cancer	2.32e-06	0.000104	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ABCB1—ovarian cancer	2.32e-06	0.000104	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CD—ovarian cancer	2.32e-06	0.000104	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PIK3CA—ovarian cancer	2.31e-06	0.000103	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.3e-06	0.000103	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TYMS—ovarian cancer	2.28e-06	0.000102	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.28e-06	0.000102	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SMARCA4—ovarian cancer	2.27e-06	0.000102	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CG—ovarian cancer	2.27e-06	0.000102	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYTB—ovarian cancer	2.25e-06	0.000101	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC2A1—ovarian cancer	2.25e-06	0.0001	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EREG—ovarian cancer	2.22e-06	9.93e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.22e-06	9.93e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.21e-06	9.88e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.2e-06	9.86e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.2e-06	9.84e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP2—ovarian cancer	2.2e-06	9.83e-05	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—ovarian cancer	2.19e-06	9.81e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.17e-06	9.7e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CAV1—ovarian cancer	2.16e-06	9.66e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1B1—ovarian cancer	2.15e-06	9.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.14e-06	9.56e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—FASN—ovarian cancer	2.13e-06	9.54e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—FASN—ovarian cancer	2.11e-06	9.44e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—BRIP1—ovarian cancer	2.11e-06	9.44e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPP1CC—ovarian cancer	2.11e-06	9.44e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTEN—ovarian cancer	2.11e-06	9.43e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—ovarian cancer	2.1e-06	9.41e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC5A5—ovarian cancer	2.1e-06	9.39e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CD—ovarian cancer	2.08e-06	9.31e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC5A5—ovarian cancer	2.08e-06	9.29e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MTOR—ovarian cancer	2.08e-06	9.29e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CB—ovarian cancer	2.08e-06	9.29e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CB—ovarian cancer	2.07e-06	9.28e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.06e-06	9.23e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC2A1—ovarian cancer	2.03e-06	9.07e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CB—ovarian cancer	2.02e-06	9.04e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC2A1—ovarian cancer	2.01e-06	8.97e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2e-06	8.97e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—YAP1—ovarian cancer	2e-06	8.93e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CD—ovarian cancer	1.99e-06	8.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.97e-06	8.84e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.97e-06	8.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.97e-06	8.82e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CG—ovarian cancer	1.97e-06	8.8e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.96e-06	8.76e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1B—ovarian cancer	1.95e-06	8.72e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.94e-06	8.69e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FASN—ovarian cancer	1.94e-06	8.69e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PARP1—ovarian cancer	1.93e-06	8.65e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.92e-06	8.6e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—YAP1—ovarian cancer	1.92e-06	8.58e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPP2R1A—ovarian cancer	1.91e-06	8.54e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.9e-06	8.5e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.9e-06	8.49e-05	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—ovarian cancer	1.89e-06	8.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC2A1—ovarian cancer	1.85e-06	8.26e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.84e-06	8.25e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—ovarian cancer	1.84e-06	8.23e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CAV1—ovarian cancer	1.84e-06	8.22e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—ovarian cancer	1.83e-06	8.17e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CB—ovarian cancer	1.81e-06	8.11e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.8e-06	8.07e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.8e-06	8.07e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.8e-06	8.07e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—ovarian cancer	1.79e-06	8.02e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—ovarian cancer	1.79e-06	8.02e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ABCB1—ovarian cancer	1.77e-06	7.93e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.75e-06	7.85e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—ovarian cancer	1.75e-06	7.82e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TYMS—ovarian cancer	1.74e-06	7.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CB—ovarian cancer	1.74e-06	7.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.74e-06	7.77e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CD—ovarian cancer	1.73e-06	7.74e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.72e-06	7.71e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	1.71e-06	7.63e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.7e-06	7.63e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—ovarian cancer	1.68e-06	7.54e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CG—ovarian cancer	1.67e-06	7.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—FASN—ovarian cancer	1.63e-06	7.28e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—ovarian cancer	1.6e-06	7.18e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—ovarian cancer	1.6e-06	7.16e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC5A5—ovarian cancer	1.6e-06	7.16e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ABCB1—ovarian cancer	1.6e-06	7.16e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ABCB1—ovarian cancer	1.58e-06	7.08e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TYMS—ovarian cancer	1.57e-06	7.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PPP2R1A—ovarian cancer	1.57e-06	7.02e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—ovarian cancer	1.57e-06	7.01e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.57e-06	7.01e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—FASN—ovarian cancer	1.56e-06	7e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TYMS—ovarian cancer	1.55e-06	6.96e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC2A1—ovarian cancer	1.55e-06	6.91e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.54e-06	6.88e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK3—ovarian cancer	1.53e-06	6.86e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.51e-06	6.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.51e-06	6.77e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CB—ovarian cancer	1.51e-06	6.74e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—ovarian cancer	1.5e-06	6.72e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—ovarian cancer	1.49e-06	6.67e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—ovarian cancer	1.49e-06	6.65e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.49e-06	6.65e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1B1—ovarian cancer	1.48e-06	6.63e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CD—ovarian cancer	1.47e-06	6.58e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK1—ovarian cancer	1.46e-06	6.52e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—ovarian cancer	1.46e-06	6.52e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.44e-06	6.42e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.42e-06	6.37e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—YAP1—ovarian cancer	1.41e-06	6.33e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CAV1—ovarian cancer	1.4e-06	6.28e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—ovarian cancer	1.38e-06	6.16e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.34e-06	6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—YAP1—ovarian cancer	1.32e-06	5.91e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPP2R1A—ovarian cancer	1.31e-06	5.88e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.31e-06	5.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.31e-06	5.85e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—ovarian cancer	1.3e-06	5.83e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CB—ovarian cancer	1.28e-06	5.73e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.28e-06	5.72e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—ovarian cancer	1.28e-06	5.72e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CAV1—ovarian cancer	1.27e-06	5.66e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—ovarian cancer	1.27e-06	5.66e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—ovarian cancer	1.26e-06	5.66e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.26e-06	5.65e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CAV1—ovarian cancer	1.25e-06	5.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—ovarian cancer	1.25e-06	5.58e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—ovarian cancer	1.23e-06	5.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—ovarian cancer	1.22e-06	5.46e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—ovarian cancer	1.21e-06	5.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TYMS—ovarian cancer	1.2e-06	5.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.17e-06	5.25e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—ovarian cancer	1.17e-06	5.24e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—FASN—ovarian cancer	1.15e-06	5.16e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—ovarian cancer	1.15e-06	5.16e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CAV1—ovarian cancer	1.15e-06	5.16e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMS—ovarian cancer	1.15e-06	5.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.15e-06	5.14e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—ovarian cancer	1.14e-06	5.11e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.13e-06	5.07e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CD—ovarian cancer	1.12e-06	5.03e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—ovarian cancer	1.12e-06	5.01e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—ovarian cancer	1.11e-06	4.95e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—ovarian cancer	1.11e-06	4.95e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.1e-06	4.9e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6ST—ovarian cancer	1.09e-06	4.89e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FASN—ovarian cancer	1.08e-06	4.82e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—ovarian cancer	1.06e-06	4.74e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.06e-06	4.74e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.05e-06	4.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—ovarian cancer	1.05e-06	4.7e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—ovarian cancer	1.03e-06	4.62e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—ovarian cancer	1.03e-06	4.62e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.02e-06	4.58e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CD—ovarian cancer	1.01e-06	4.54e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—ovarian cancer	1.01e-06	4.5e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CD—ovarian cancer	1e-06	4.49e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1e-06	4.48e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1B1—ovarian cancer	9.81e-07	4.39e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CB—ovarian cancer	9.79e-07	4.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CAV1—ovarian cancer	9.66e-07	4.32e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	9.31e-07	4.17e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CAV1—ovarian cancer	9.28e-07	4.15e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CD—ovarian cancer	9.23e-07	4.13e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.22e-07	4.13e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—ovarian cancer	9.19e-07	4.11e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—ovarian cancer	9.03e-07	4.04e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CB—ovarian cancer	8.84e-07	3.95e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—ovarian cancer	8.8e-07	3.94e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CB—ovarian cancer	8.74e-07	3.91e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	8.7e-07	3.89e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.66e-07	3.87e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—ovarian cancer	8.66e-07	3.87e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMS—ovarian cancer	8.49e-07	3.8e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—ovarian cancer	8.46e-07	3.79e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—ovarian cancer	8.45e-07	3.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—ovarian cancer	8.15e-07	3.65e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—ovarian cancer	8.08e-07	3.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CB—ovarian cancer	8.05e-07	3.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTOR—ovarian cancer	8.05e-07	3.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMS—ovarian cancer	7.94e-07	3.55e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—ovarian cancer	7.81e-07	3.5e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CD—ovarian cancer	7.73e-07	3.46e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—ovarian cancer	7.64e-07	3.42e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—ovarian cancer	7.56e-07	3.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—ovarian cancer	7.55e-07	3.38e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—ovarian cancer	7.51e-07	3.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CD—ovarian cancer	7.43e-07	3.32e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—ovarian cancer	7.13e-07	3.19e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—ovarian cancer	6.95e-07	3.11e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CAV1—ovarian cancer	6.84e-07	3.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CB—ovarian cancer	6.74e-07	3.02e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CB—ovarian cancer	6.48e-07	2.9e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CAV1—ovarian cancer	6.39e-07	2.86e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—ovarian cancer	6.38e-07	2.86e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—ovarian cancer	6.23e-07	2.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—ovarian cancer	6.22e-07	2.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—ovarian cancer	6.2e-07	2.78e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.11e-07	2.73e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—ovarian cancer	5.97e-07	2.67e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK3—ovarian cancer	5.94e-07	2.66e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.82e-07	2.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—ovarian cancer	5.82e-07	2.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—ovarian cancer	5.78e-07	2.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK1—ovarian cancer	5.65e-07	2.53e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—ovarian cancer	5.65e-07	2.53e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—ovarian cancer	5.6e-07	2.5e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CD—ovarian cancer	5.48e-07	2.45e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—ovarian cancer	5.39e-07	2.41e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—ovarian cancer	5.34e-07	2.39e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—ovarian cancer	5.33e-07	2.39e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	5.12e-07	2.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—ovarian cancer	4.91e-07	2.19e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—ovarian cancer	4.88e-07	2.18e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.78e-07	2.14e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—ovarian cancer	4.54e-07	2.03e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.46e-07	2e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—ovarian cancer	4.4e-07	1.97e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—ovarian cancer	4.35e-07	1.95e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—ovarian cancer	4.34e-07	1.94e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—ovarian cancer	4.13e-07	1.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—ovarian cancer	4.11e-07	1.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—ovarian cancer	4.01e-07	1.79e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—ovarian cancer	3.95e-07	1.77e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—ovarian cancer	3.86e-07	1.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—ovarian cancer	3.36e-07	1.5e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—ovarian cancer	3.23e-07	1.44e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.91e-07	1.3e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.72e-07	1.22e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—ovarian cancer	2.38e-07	1.06e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—ovarian cancer	2.22e-07	9.94e-06	CbGpPWpGaD
